Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity.

Author: ChenChengshui, ChenGuowu, DongNian, GuWenwen, NiZhong, SunXiaoxi, WangJian, WangShuangjie, XinAijie, XuWenping, YangJun, YangLong, ZengBubing, ZhangXu

Paper Details 
Original Abstract of the Article :
Tamoxifen is administered for estrogen receptor positive (ER<sup>+</sup>) breast cancers, but it can induce uterine endometrial cancer and non-alcoholic fatty liver disease (NAFLD). Importantly, ten years of tamoxifen treatment has greater protective effect against ER<sup>+</sup> breast cancer than ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339706/

データ提供:米国国立医学図書館(NLM)

Anordrin: A New Oasis in the Desert of Tamoxifen Side Effects

Tamoxifen, a powerful medication used to treat breast cancer, can unfortunately come with unwanted side effects. This study explores the potential of anordrin, a medication marketed in China, to mitigate these side effects without compromising the anti-tumor activity of tamoxifen. Imagine a desert where a traveler is facing the harsh realities of Tamoxifen’s side effects. Anordrin is like a hidden oasis, offering a safe haven and mitigating the negative impacts of the journey.

A Balancing Act in the Desert: Anordrin and Tamoxifen

The researchers discovered that anordrin can effectively reduce the side effects of tamoxifen, particularly those affecting the uterus and liver, without diminishing its anti-tumor activity. It’s like finding a way to use a strong but potentially dangerous desert wind to your advantage, channeling its power while mitigating its negative impacts. This finding is a significant advancement in breast cancer treatment, offering a more manageable and effective approach.

A Safer Journey: Anordrin and its Promise for Breast Cancer Patients

Anordrin represents a potential breakthrough in breast cancer treatment, offering a safer and more tolerable pathway for patients. It’s like finding a well-protected path through the desert, allowing patients to focus on their recovery without the burden of severe side effects. Further research is crucial to confirm its long-term benefits, but the initial findings are promising.

Dr. Camel’s Conclusion

This research illustrates the power of innovation in addressing the challenges of medication side effects. It’s like finding a way to make a desert journey more comfortable and less risky. By carefully combining medications and understanding their interactions, we can create a safer and more effective path to healing for patients battling breast cancer. This research reminds us that even in the face of complex medical challenges, hope and progress are always possible.

Date :
  1. Date Completed 2018-11-14
  2. Date Revised 2018-11-14
Further Info :

Pubmed ID

28266626

DOI: Digital Object Identifier

PMC5339706

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.